One small problem still exists...the cost...most physicians can't afford to keep the vaccine in house...BD 
FDA has granted priority review status to Merck's application to expand marketing of its human papillomavirus vaccine Gardasil to women ages 27 to 45, the company said Wednesday, Reuters reports. The designation means that an FDA decision could come within six months, according to Reuters. currently is approved by the FDA for use by girls and women ages nine to 26 (Reuters, 3/19).
FDA To Review Merck's Application To Expand HPV Vaccine Gardasil's Approval To Older Women
0 comments :
Post a Comment